Your half hour of diagnostic power
Individuals shown are models, not actual patients or healthcare professionals.

In just 30 minutes,* diagnose coronary artery disease
Don’t compromise.
Get the COMPLETE package of diagnostic information to help manage and treat your patients with suspected coronary artery disease—all in just one efficient 30-minute* cardiac PET imaging protocol.
On-demand generator-based imaging means your dose is always on site and ready when you are.
- Data at patient rest and stress at true peak hyperemia
- Valuable MBF data and coronary flow capacity maps with HeartSee™
- Proven safety with low radiation exposure for staff and patients1,2
- Easily accommodate patient add-ons and enjoy simple scheduling
Bracco believes cardiac PET imaging should be available to all patients and providers.
We offer customized daily-use solutions if you can’t commit to the operational costs of a full-time imaging program or have low patient volumes.
*Protocols may vary slightly by site.
There is POWER in every minute.
Get all the diagnostic and operational benefits of cardiac PET imaging along with the unmatched clinical, business, and reimbursement support that only Bracco can offer.


INDICATIONS FOR USE
HeartSee Software for cardiac positron emission tomography (PET) is indicated for determining regional and global absolute rest and stress myocardial perfusion in cc/min/g, Coronary Flow Reserve and their combination into the Coronary Flow Capacity (CFC) Map in patients with suspected or known coronary artery disease (CAD) in order to assist clinical interpretation of PET perfusion images by quantification of their severity.
HeartSee is intended for use by trained professionals such as nuclear technicians, nuclear medicine or nuclear cardiology physicians, or cardiologists with appropriate training and certification. The clinician remains ultimately responsible for the final assessment and diagnosis based on standard practices, clinical judgment and interpretation of PET images or quantitative data.
HEARTSEE is a trademark of The University of Texas Health Science Center at Houston on behalf of the Board of Regents of The University of Texas System, and used under a license by Bracco Diagnostics Inc.
REFERENCES:
- Bateman TM, Dilsizian V, Beanlands RS, DePuey EG, Heller GV, Wolinsky DA. American Society of Nuclear Cardiology and Society of Nuclear Medicine and Molecular Imaging Joint Position Statement on the Clinical Indications for Myocardial Perfusion PET. J Nucl Med. 2016;57(10):1654-1656. doi:10.2967/jnumed.116.180448
- Schleipman AR, Castronovo FP Jr, Di Carli MF, Dorbala S. Occupational radiation dose associated with Rb-82 myocardial perfusion positron emission tomography imaging. J Nucl Cardiol. 2006;13(3):378-384. doi:10.1016/j.nuclcard.2006.03.001



